Bai Y; Zhang J; Li J, et al., Silibinin, a commonly used therapeutic agent for non-alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19. Br J Pharmacol 2024.
Zhao P; Sun X; Li H, et al., c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation. Cancers (Basel) 2022, 14 (3).
Zhang J; Wang W; Liang S, et al., Butyrate induces STAT3/HIF-1alpha/IL-22 signaling via GPCR and HDAC3 inhibition to activate autophagy in head kidney macrophages from turbot (Scophthalmus maximus L.). Fish Shellfish Immunol 2023, 143, 109214.
